Hexima
  • Home
  • About
    • About Hexima
    • Management Team
    • Board of Directors
  • Products
    • HXP124
    •   > Clinical Trials
  • Technology
    • Antifungal Plant Defensins
  • Publications
    • Peer Reviewed Papers
    • Posters and Presentations
    • Patents
    • Hexima in the Media
  • Investors
    • Corporate Governance
    • Announcements
    • Annual & Interim Reports
    • Share Price
    • Investor Services
    • Investor Contacts
  • Contact
Select Page

Interim Financial Report for the 6 Months Ended 31 December 2016

Mar 10, 2017 | Annual financial reports, Financial updates

Hexima Financials Banner

View Hexima’s Interim Financial Report (pdf) for the 6 months ended 31 December 2017.

Archives

Categories

Site Search

About us

Hexima is a biotechnology company actively engaged in the research and development of plant-derived proteins and peptides for applications as human therapeutics.

Contact

La Trobe Institute for Molecular Science
Level 4, LIMS2
La Trobe University VIC 3086
Australia

Phone: +61 3 9479 1210

Stay up to date

For the latest shareholder information & investor news, subscribe to our email alerts.

  • RSS

Site Design: Paraph. Hosting, updates & security: 4tify